Ginger shot without sugar targets skin autoimmune diseases via 4 molecular axes: (1) psoriasis-eczema-peau-inflammatoire">ginger psoriasis — inflammation-mecanisme-cle-ginger-sucre-explication-2026">NF-κB keratinocytes↓ (IL-8/CXCL1↓), IL-17/IL-23 axis↓ (Th17→Treg rebalancing), keratinocyte proliferation↓ (AMPK→mTORC1↓); (2) Vitiligo — Nrf2↑ in melanocytes (H₂O₂↓ via catalase/GPx), TNF-α melanocytotoxic↓, CXCL10↓ (CD8 recruitment↓); (3) Lichen planus — NF-κB epithelial↓, Treg↑. INTI vs GIMBER comparison ~35g sugar/100ml → AGE → cutaneous NF-κB↑ → psoriasis/vitiligo exacerbated. INTI 1.19g/100ml.
Advanced Psoriasis: Systemic Disease Beyond Plaques
Moderate to severe psoriasis (PASI >10) is a systemic disease: dermal inflammation (IL-17, IL-22, TNF-α) + accelerated keratinocyte proliferation (cell cycle from 28 days to 3-4 days) + cardiovascular comorbidities, psoriatic arthritis, and metabolic syndrome. NF-κB is the central orchestrator:
- NF-κB keratinocytes → IL-8/CXCL1 → neutrophil recruitment → Munro's microabscesses
- NF-κB dermal dendritic cells → IL-23 → Th17 differentiation → IL-17A/F/C → self-sustaining cascade
- NF-κB vascular → VEGF → dermal hypervascularization (characteristic redness)
Ginger Mechanisms in Skin Autoimmune Diseases
| Dermatosis | Key Mechanism | Ginger Effect | Data |
|---|---|---|---|
| Psoriasis | NF-κB keratinocytes → IL-8/CXCL1 | IL-8 -45% (6-gingerol 10µM) | In vitro HaCaT keratinocytes |
| IL-17/IL-23 axis → Th17 | IL-17A -30%, Th17/Treg normalized | Imiquimod mouse models | |
| mTORC1 → keratinocyte proliferation | AMPK↑ → mTORC1↓ → proliferation -35% | Epidermal thickness -40% | |
| Vitiligo | H₂O₂ ↑ → melanocyte apoptosis | Nrf2/CAT/GPx↑ → H₂O₂ neutralized | Melanocyte survival +40% |
| CXCL10 → CD8-cytotoxic | CXCL10 -35%, dermal CD8↓ | Melanocytic autoimmunity↓ | |
| Lichen Planus | NF-κB epithelial + Th1/Th17 infiltrate | Treg↑, IL-10↑, NF-κB↓ → infiltrate moderated | Oral IL-17 -28% |
Psoriasis and Metabolic Syndrome: The Sugar Connection
Psoriasis is closely linked to metabolic syndrome (obesity, insulin resistance). Hyperglycemia:
- Activates dermal NF-κB → enhances IL-17/IL-23 → more severe plaques
- Cutaneous AGEs → cross-linked collagen → slow wound healing + chronic inflammation
- Obesity → adipokines (leptin, resistin) → Th17 polarization → exacerbated psoriasis
| Product | Sugar/100ml | Psoriasis Impact |
|---|---|---|
| GIMBER | ~35g | ❌ NF-κB↑, cutaneous AGEs↑, Th17 aggravated |
| Coca-Cola | 10.6g | ❌ Reference (GIMBER = 3.3×) |
| INTI | <4g | ✅ NF-κB↓, AGEs↓, Th17/Treg rebalanced |
INTI Protocol — Autoimmune Dermatoses
| Dermatosis | INTI Dose | Synergies |
|---|---|---|
| Plaque Psoriasis | 2-3 shots/day | Omega-3 EPA (IL-17↓), Vitamin D (Treg↑), Mediterranean diet |
| Vitiligo (adjunctive) | 2 shots/day | Vitamin E (Nrf2 synergy), Polypodium leucotomos (photoprotection), L-phenylalanine |
| Oral Lichen Planus | 2 shots + 30 sec gargling | Turmeric (NF-κB), aloe vera (mucosa) |
❓ FAQ — Ginger and Skin Autoimmune Diseases
Can ginger replace biologics (anti-IL-17) for psoriasis?
No — biologics are indicated for moderate to severe psoriasis and remain the reference treatment. Ginger is complementary for background inflammation and dietary support.
How long until visible effects on psoriasis?
NF-κB reduction begins within weeks. Visible effects on plaques (via AMPK→mTORC1↓ and Th17↓) require 8-12 weeks of continuous intake combined with an anti-inflammatory diet.
Does ginger help with active vitiligo?
As an adjunct — Nrf2 protection of residual melanocytes and CXCL10 reduction can slow progression. Active vitiligo requires dermatological follow-up and often NB-UVB phototherapy.
INTI inhibits IL-17/IL-23, protects melanocytes via Nrf2, and rebalances Th17/Treg — without the sugar of GIMBER (3.3× Coca-Cola) that enhances cutaneous NF-κB.
Discover INTI — ginger skin autoimmune →Related articles
Read more about related topics :
- Ginger and Psoriasis: Reducing Plaques, IL-17/IL-23 Inflammation, and Itching Naturally
- schildklier-hashimoto-hypothyreoidie-knobbels-nf-kb-th17-treg-tpo-nrf2-inti">Ginger and Thyroid: thyroide-hashimoto-hypothyroidie">ginger Hashimoto, hypothyroidism and nodules — NF-κB, Th17/Treg and TPO — INTI
- Ginger and Psoriatic Arthritis and Spondylitis: IL-17, IL-23, TNF-α and Enthesitis — Immuno-Inflammatory Mechanisms
- Ginger and Rheumatoid Arthritis: IL-17, Th17/Treg, TNF-α and PDGF — Advanced Mechanisms
- Ginger & Vitiligo: Oxidative Stress, NRF2 and Melanocytes (2025)
- Psoriasis in Belgium: Sugar, IL-17, Th17 and Ginger (2025)
- Psoriasis in Belgium: Sugary Drinks, Gut-Skin Axis and Ginger as an Inflammation Modulator
- Ginger and Multiple Sclerosis: Myelination, Neuroinflammation and Th17/Treg Central — BDNF and NF-κB — INTI